OncoImmune Competitors and Similar CompaniesClear all

OncoImmune's competitors and similar companies include AstraZeneca and Telix Pharmaceuticals.

	OncoImmune OncoImmune is a clinical-stage biopharmaceutical company engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
Founding Date	Founding Date 2000	Founding Date 1999	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Rockville, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more
Employees	Employees 9	Employees 94,300	Employees 415
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) 4.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) $803.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)	Cost of goods $356m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $54.2b (FY, 2025)	Gross profit $449m (FY, 2025)
Net income	Net income N/A	Net income $10.2b (FY, 2025)	Net income ($7.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 71.8m	Total funding raised $ 1b	Total funding raised N/A